Akili, Inc. , a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning.
Akili stock last closed at $0.23, up 8.92% from the previous day, and has decreased 83.66% in one year. It has underperformed other stocks in the Health Information Services industry by 0.56 percentage points. Akili stock is currently +21.47% from its 52-week low of $0.19, and -86.11% from its 52-week high of $1.67.
As of Apr 18, 2024, there are 78.51M shares of AKLI outstanding. The market value of AKLI is $18.21M. In the past 24 hours, 202,063 AKLI shares were traded.
You need a brokerage account to access the NASDAQ market and buy AKLI stock.
Based on our experience, eToro is the best place to buy stocks. Here's why:
Get $10 towards your share purchase by opening an account with eToro now.
Open eToro AccountNow that you've picked the best brokerage, the next step is to fill out some personal information so you can buy AKLI stock today.
Now that you've finished signing up on the best beginner stock app, you need to deposit funds:
Watch the walkthrough below for more details depositing money into your investment account.
Once you have decided on the best place to buy Akili stock, it's very important to research their stock prior to buying, so you can understand the risk and upside.
WallStreetZen was created to help everyday investors do better fundamental analysis in less time.
You can see all of the due diligence checks on AKLI's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge AKLI's fair value.
Using relative valuations metrics:
You can access more valuation research on AKLI's stock here.
You can dive deeper into what analysts are forecasting on the Akili stock forecast page.
Last year, AKLI revenue was $1.68M. In the last three year, AKLI's revenue has grown by -83.11% per year. This was slower than the Health Information Services industry average of 19.86%.
Find out more about AKLI's earnings and revenue performance here.
In the last 12 months, insiders at AKLI have sold more shares than they have bought.
Matthew Franklin, President CEO of AKLI, was the latest AKLI insider to sell. They sold $549.10 worth of AKLI shares on Mar 10, 2024.
Learn more about who owns AKLI stock here.
No, Akili doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
You have two primary options:
Click the Open Trade button and eToro will execute your order.
If you require more assistance investing in stocks on eToro, click the helpful video below:
Now that you own some AKLI shares, you'll want to keep up with your new investment.
Start a watchlist to track the latest developments regarding your AKLI stock.
To reiterate, here are the 6 steps to buy Akili stock:
If you require a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to track your new investment in Akili, create a watchlist today.